I&I B10/11

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/62

flashcard set

Earn XP

Description and Tags

Autoimmunity, Cancer immunotherapy

63 Terms

1
New cards

What causes Type I autoimmunity responses?

IgE (inflammatory mediator release)

2
New cards

What causes Type II autoimmunity responses?

IgG or IgM (complement-mediated lysis or antibody-dependent cellular cytotoxicity)

3
New cards

What causes Type III hypersensitivity?

deposition of antibody:antigen complexes on surfaces triggers release of inflammatory mediators and vasoactive mediators

4
New cards

What complications can arise from Type III hypersensitivity? (2)

Proteases released may damage connective tissues

Clots may form as complexes activate platelets

5
New cards

What causes Type IV hypersensitivity?

antigen sensitization by an initial exposure triggers production of a T-cell response, second exposure to the Ag (takes 24-72h) induces production of inflammatory cytokines

6
New cards

Which hypersensitivity response is also known as “delayed type“?

IV

7
New cards

Prolonged inability to clear Ag in Type IV hypersensitivity can result in formation of what? (2)

Multinucleated giant cells (macrophages)

Granulomas (macrophages and T cells)

8
New cards

What hypersensitivity responses can cause autoimmunity?

chronic II, III and/or IV

9
New cards

5 main mechanisms by which self-tolerance can be broken

inflammatory activation

molecular mimicry

epitope spreading

Exposure of sequestered antigens

Defective immune regulation

10
New cards

Which genes are the strongest genetic component of most autoimmune diseases?

HLA

11
New cards

Mutations in what genes are associated with autoimmunity?

AIRE

CTLA4

FOXP3

FAS

C1q

12
New cards

Systemic Lupus Erythematosus cause: self-antigen and mode of disease

antibodies against own DNA & histones

Immune complex deposition in multiple tissues causes inflammation.

13
New cards

Distinct Effector B Cells Induced by Unregulated (…) Contribute to Pathogenic Responses in Systemic Lupus Erythematosus

TLR7

14
New cards

What antigen is rheumatoid arthritis formed against?

unknown

15
New cards

What is the swelling pattern in arthritis?

usually bilaterally symmetrical in joints

16
New cards

Which MHC component is rheumatoid arthritis associated with?

HLA-DR4

17
New cards

What are the a) cells and b) cytokines involved in rheumatoid arthritis?

a) T cells, B cells, macrophages, neutrophils.

b) TNFα, IL-1β, GM-CSF

18
New cards

What causes the main symptom of Myasthenia Gravis?

antibodies are formed against the acetylcholine receptor, interfering with neurotransmitter signals at neuromuscular junction and causing muscle weakness

19
New cards

What MHC II alleles are associated with Diabetes type 1?

HLA-DR3, HLA-DR4

20
New cards

Treating symptoms (e.g. Pain relief, replacing insulin) •Anti-inflammatory drugs (e.g. corticosteroids, COX-2 inhibitors, cyclophosphamide, cyclosporin A in T1D) •Use of cytokines to modify immune response (e.g. Type I interferon) •Targeted biological therapies against key cytokines or cell types involved pathogenesis (e.g. anti-TNF, anti-IL-1, anti-GM-CSF, anti-CD20, anti-CD3) •Blocking trafficking of immune cells to site of pathology (Block adhesion molecules or chemokines) •Better understanding of the molecular mechanisms of autoimmune pathologies should enable better drug targets for more effective treatments or cure

21
New cards

What is the autoimmune target in multiple sclerosis?

myelin sheath

<p>myelin sheath</p>
22
New cards

What is the myelin sheath made up of and in what proportions?

70% lipid, 30% proteins

23
New cards

TRUE OR FALSE: multiple sclerosis is genetic

TRUE: Risk increases 15-20 fold if first degree relatives have it

24
New cards

Concordance rate of multiple sclerosis is higher in (di/mono)zygotic twins

Concordance rate of multiple sclerosis is higher in monozygotic twins

25
New cards

Multiple genes in what pathway are multiple sclerosis risk genes?

vitamin D; Low serum levels associated with higher risk of developing MS

26
New cards

Vitamin D has what effects on the immune system? (4)

  • expression of MHC-II

  • cytokine expression

  • inhibits T cell activation

  • increases production of immunosuppressive factors in the CNS


27
New cards

Two viruses that have been most established associations with multiple sclerosis

Epstein Barr virus, human herpes virus-6

28
New cards

What cytokines produced by CD4+ T cells are implicated in multiple sclerosis and how? (3)

  • IL-17 promotes neutrophil recruitment

  • IFNγ promotes cytotoxic CD8 T cells and activates macrophages

  • GM-CSF recruits and activates monocytes and macrophages


29
New cards

Frontline therapeutics for MS: identity, type, mechanism (3)

  • β-interferon— cytokine—alters T cell responses

  • Glatiramer acetate— amino acid copolymer— unknown mechanism

  • dimethyl fumarate—small molecule— reduces oxidative stress to suppress inflammation


30
New cards

What are the second-line therapeutics for MS and their side effects? (5)

  • Natalizumab—allergic reactions and increased infection

  • Rituximab & Ocrelizumab—immunosuppression (of B cells)

  • Fingolimod—sequesters lymphocytes in lymphoid organs

  • Cladribine—cytotoxic to lymphocytes


31
New cards

Third-line treatments for MS: identity, type/source, method (2)

  • Alemtuzumab—Monoclonal antibody—lyses all cells (including lymphocytes) that express CD52

  • Autologous HSC transplant—Patient’s own hematopoietic stem cells harvested from bone marrow—chemotherapy to kill circulating immune cells and replace with harvested ones


32
New cards

What is the murine model disease used to study multiple sclerosis? (name and mechanism)

Experimental autoimmune encephalomyelitis: CD4+ infiltration in perivascular regions and within central nervous system parenchyma.

33
New cards

What cell is speculated to drive pathogenesis of Experimental autoimmune encephalomyelitis?

Th1

34
New cards

How do the pathogens (+ what?) develop in Experimental autoimmune encephalomyelitis?

  1. DC + CD4 + IL-6 + TGFβ → Th17

  2. Th17 + IL-23 → GM-CSF

  3. GM-CSF → IL-17 + IFNγ


35
New cards

Pathogenic (…) cells that make GM-CSF express (…) and not (…) and require (…) to migrate to the CNS and cause EAE.

Pathogenic Th17 cells that make GMC-SF express CCR2 and not CCR6 and require CCR2 to migrate to the CNS and cause EAE.

36
New cards

Immune cells commonly found in established solid tumours (5)

Macrophages, neutrophils, memory CD4+ and CD8+ T cells, Tregs

37
New cards

What are the two types of immune responses that affect the nature of the tumour cell compositions and how?

cold: immunosuppressive cells→ Poor penetration of anti-tumour T cells

hot: anti-tumour T cells→ inflamed

<p>cold: immunosuppressive cells→ Poor penetration of anti-tumour T cells</p><p>hot: anti-tumour T cells→ inflamed </p>
38
New cards

What is associated with positive patient outcome in cancer?

increased density of CD3+ or CD8+ T cells at the invasive margin of the tumour

39
New cards

What is a a) benefit and b) disadvantage of tumour specific T cells?

a) destroy tumour cells

b) pressure of anti-tumour immune response drives emergence of tumour variants with reduced antigenicity

40
New cards

What are the steps in immunoediting in cancer? (3)

HINT: the three E’s

  1. elimination: T cells targeting tumours

  2. equilibrium: dormant state and editing of tumour, less signals for T cell activity

  3. escape: no longer recognized by T cell


41
New cards

Tumour Associated Antigens are classified into what 3 groups?

  • mutant self-proteins

  • Overexpressed self protein

  • Viral oncogenes associated with tumour progress


42
New cards

How do NK cells recognise tumours? (2)

  • Downregulation of MHC Class I molecule

  • NKG2D activating receptors on NK cells binds stress ligands expressed on many tumours, overriding inhibitory receptor signaling


43
New cards

How can macrophages a) inhibit and b) help tumour cells?

a) release of ROS and cytokines, role in immunosurveillance

b) favour tumour growth and metastasis (spread) of established tumours

44
New cards

tumour eradication by immune system (4 steps)

  1. Tumour Associated Antigens are picked up by cross-presenting cDC1s

  2. DCs migrate to LN and present TAAs to CD8+ T cells (with MHC I)

  3. Clonal selection: CD8+ T cell proliferation and differentiation

  4. Tumour-specific CTLs leave LN and migrate to the tumour and kill tumour cells


45
New cards

The immune response will fail to negate tumours if it fails to… (3)

  • adequately prime anti-tumour immunity

  • effectively migrate into solid tumours

  • function in the tumour microenvironment


46
New cards

Do cells already have tumour tolerant phenotypes, or does the cancer skew the responses to favour it?

Both can be the case!

47
New cards

What specific cells can be attracted by the tumour to inhibit the immune response? (3)

  • Tumour associated/ M2-like Macrophages: favour tissue generation

  • Tregs: suppress anti-tumour immune response

  • Tolerogenic DCs: inhibit T cell activation


48
New cards

T cell exhaustion

In chronic conditions, T cells can receive too much engagement and become hyporesponsive in an attempt to avoid overwhelming the body by upregulating inhibitory receptors

49
New cards

What makes anti-tumour immunotherapies better than, say, chemotherapy? (2)

  • can induce immune T cell memory

  • specific to tumour cells to avoid damaging healthy cells


50
New cards

What anti-tumour immunotherapies are in use? (3)

  • Cytolytic and neutralising mAbs

  • Immune checkpoint inhibitors

  • Adoptive T cell therapy (CAR-T cells)


51
New cards

monoclonal antibodies

a crop of antibody molecules specific to a single antigen

52
New cards

a) what are conjugated mAbs conjugated to and b) what do they cause?

a) radioisotope (or responsive to radiotherapy), or drug that may be too toxic to use alone

b) apoptosis from toxic payload

<p>a) radioisotope (or responsive to radiotherapy), or drug that may be too toxic to use alone</p><p>b) apoptosis from toxic payload</p>
53
New cards

What are bi-specific mAbs/ their goals?

target two different antigens on immune cells and tumour cells to force contact

54
New cards

What are the two types of bi-specific mAb?

  • 2 Ab binding sites linked by Fc

  • 2 Ab binding sites directly joined (BiTE)


55
New cards

what is the in vitro modification of patients’ T cells in a) Adoptive T cell and b) CAR-T therapy?

a) expanded against tumour antigens

b) Expanded and genetically-modified to express recombinant Chimeric Antigen Receptors

56
New cards

What are the components of a CAR-T cell? (4)

  • Single chain variable fragment of an antibody (scFv) targeted against tumour antigen

  • Linker

  • CD3 Intracellular signaling domain

  • CD28, 41BB intracellular costimulatory molecules


<ul><li><p>Single chain variable fragment of an antibody (scFv) targeted against tumour antigen</p></li></ul><ul><li><p>Linker </p></li><li><p>CD3 Intracellular signaling domain</p></li><li><p>CD28, 41BB intracellular costimulatory molecules </p></li></ul><p></p>
57
New cards

Can CAR-T cells express cytokines?

4th generation ones can release perforin and granzyme

58
New cards

What MHC do CAR-T cells require for activation?

neither; recognize tumour directly

<p>neither; recognize tumour directly</p>
59
New cards

CAR-T cells dangers/ problems? (3)

  • Cytokine release syndrome; systemic inflammatory response

  • Immune cell associated neurotoxicity syndrome

  • Off target cytotoxicity


60
New cards

Oncolytic viruses

attenuated/naturally non-pathogenic viruses that selectively infect/lyse tumor cells due to tumor cells either overexpressing virus receptor or being unable to produce anti-viral proteins

61
New cards

Oncolytic viruses dangers/ problems? (4)

  • Immunosuppressed patients

  • limited efficacy in advanced cancers

  • pre-existing anti-viral immunity

  • limited re-use


62
New cards
knowt flashcard image
63
New cards

What are the two types of diabetes and which one is autoimmune?

Type I: loss of insulin producing cells— autoimmune

Type II: Insulin resistance develops